Video Experimental Relacionado
Updated: Jul 7, 2026
06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Interacciones entre el humo de segunda mano y los genes que afectan la enfermedad pulmonar de la fibrosis quística
J Michael Collaco1, Lori Vanscoy, Lindsay Bremer
1Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
JAMA
|January 31, 2008
Resumen
La exposición al humo de segunda mano empeora significativamente la función pulmonar en pacientes con fibrosis quística (FC). Las variaciones genéticas específicas, incluidas CFTR y TGFbeta1, amplifican estos efectos nocivos, lo que resalta la importancia de evitar la exposición al humo para las personas con FQ.
Área de la Ciencia:
- Medicina Pulmonar La medicina pulmonar es el tratamiento de las enfermedades pulmonares.
- Genética La genética.
- Salud Ambiental Salud del medio ambiente.
Sus antecedentes:
- La fibrosis quística (FQ) exhibe una variación significativa de la enfermedad a pesar de una etiología de un solo gen.
- Investigar las interacciones entre genes y medio ambiente es crucial para comprender la heterogeneidad de las enfermedades.
Objetivo del estudio:
- Evaluar la asociación entre la exposición al humo de segunda mano (SHS) y la función pulmonar en individuos con FQ.
- Para determinar si el estatus socioeconómico (SES) influye en la relación SHS-enfermedad pulmonar.
- Para identificar las interacciones entre el gen y el medio ambiente que afectan el impacto de SHS en la función pulmonar de la FQ.
Principales métodos:
- Análisis retrospectivo de los datos de la función pulmonar del Estudio de Gemelos y Hermanos de Fibrosis Quística de los Estados Unidos y el Registro de Datos de la Fundación CF.
- Estratificación por factores ambientales (exposición a SHS) y genéticos.
- Evaluación de las medidas transversales y longitudinales de la función pulmonar.
Principales resultados:
- La exposición al humo de segunda mano se relacionó con una función pulmonar transversal y longitudinal significativamente menor en pacientes con FQ.
- El estado socioeconómico no confundió los efectos adversos de SHS en la función pulmonar.
- Las variantes genéticas en CFTR y TGFbeta1 amplificaron el impacto negativo de SHS en la función pulmonar.
Conclusiones:
- Cualquier nivel de exposición al humo de segunda mano afecta negativamente la función pulmonar en personas con fibrosis quística.
- Las variaciones genéticas en los genes CFTR y TGFbeta1 exacerban los efectos perjudiciales de la exposición a SHS en la función pulmonar.
Videos de Conceptos Relacionados
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...